Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide
TP53突变的出现和演变是接受来那度胺治疗的低危del(5q)骨髓增生异常综合征患者疾病进展的关键特征。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2017.181404
Lodé, Laurence; Ménard, Audrey; Flet, Laurent; Richebourg, Steven; Loirat, Marion; Eveillard, Marion; Le Bris, Yannick; Godon, Catherine; Theisen, Olivier; Gagez, Anne-Laure; Cartron, Guillaume; Commes-Maerten, Thérèse; Villemagne, Bruno; Luycx, Odile; Godmer, Pascal; Pellat-Deceunynck, Catherine; Soussi, Thierry; Béné, Marie C; Delaunay, Jacques; Peterlin, Pierre